Matches in SemOpenAlex for { <https://semopenalex.org/work/W29704663> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W29704663 endingPage "11" @default.
- W29704663 startingPage "609" @default.
- W29704663 abstract "Case report of a 23-year-old nulliparous woman with facial melanosis manifesting itself as hyperpigmented, symmetrical areas which started during a sunny vacation is presented. Patient used oral contraceptives (Stedril-d or Ortho-Novum) for 2 years; no other drugs or cosmetics were used. Treatment with 5% hydroquinone, 0.1% triamcinolone acetonide, 0.5% tretinoin in equal parts, propyleneglycol, and ethanol 1-2 times daily for 3 months. Ortho-Novum was used during this period. No symptoms for 3 1/2 years, then recurrence after sunlight exposure. Patient used no pill at that time. Same treatment used with good results. Sunscreen (RV-paque) used for skin protection. Melasma consists of lightbrown to greyish sharply circumscribed, symmetrically localized spots. Histologically, increased melanin and some melanophages are found in dermal layers. Melasma is influenced by light and hormonal factors. Melanocyte-stimulating-hormone (MSH) promotes melanosome migration in dendrites coupled with skin darkening; it also activates tyrosinase. Progesterone acts on estrogen-primed melanocytes. These hormones play a role in pill-melasma which can occur after sunlight exposure. Melasma can result from a phototoxic or photoallergic reaction to cosmetics, tar, or other photosensitizing agents. We examined 74 patients (70 women and 4 men; ages 16-53 years) between 1973-1979. 15 patients were pregnant; 19 used the pill or other hormone therapy, 12 resulted from sunburn; there was no apparent cause in 26. Several depigmentation agents have been tested for treatment. Of these, hydroquinone had good results with minimal side effects. Mercaptamines were tested experimentally but not used therapeutically. 0.2% triamcinolone acetonide in cream base was satisfactory. Of 40 patients treated with either 5% hydroquinone, 0.5% tretinoin and 0.1% triamcinolone, or with corticosteroids only, 40% had good results with corticosteroids and 53% with the hydroquinone combination. Sunlight and cosmetics must be avoided and sunscreening agents used to prevent recurrence." @default.
- W29704663 created "2016-06-24" @default.
- W29704663 creator A5009394291 @default.
- W29704663 creator A5045628628 @default.
- W29704663 date "1981-04-18" @default.
- W29704663 modified "2023-09-23" @default.
- W29704663 title "[Facial melanosis (melasma)]." @default.
- W29704663 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7242709" @default.
- W29704663 hasPublicationYear "1981" @default.
- W29704663 type Work @default.
- W29704663 sameAs 29704663 @default.
- W29704663 citedByCount "0" @default.
- W29704663 crossrefType "journal-article" @default.
- W29704663 hasAuthorship W29704663A5009394291 @default.
- W29704663 hasAuthorship W29704663A5045628628 @default.
- W29704663 hasConcept C16005928 @default.
- W29704663 hasConcept C2776677263 @default.
- W29704663 hasConcept C2776728111 @default.
- W29704663 hasConcept C2776972258 @default.
- W29704663 hasConcept C2777148277 @default.
- W29704663 hasConcept C2777524492 @default.
- W29704663 hasConcept C2777658100 @default.
- W29704663 hasConcept C2777673923 @default.
- W29704663 hasConcept C2780846639 @default.
- W29704663 hasConcept C502942594 @default.
- W29704663 hasConcept C71924100 @default.
- W29704663 hasConcept C81603835 @default.
- W29704663 hasConcept C98274493 @default.
- W29704663 hasConceptScore W29704663C16005928 @default.
- W29704663 hasConceptScore W29704663C2776677263 @default.
- W29704663 hasConceptScore W29704663C2776728111 @default.
- W29704663 hasConceptScore W29704663C2776972258 @default.
- W29704663 hasConceptScore W29704663C2777148277 @default.
- W29704663 hasConceptScore W29704663C2777524492 @default.
- W29704663 hasConceptScore W29704663C2777658100 @default.
- W29704663 hasConceptScore W29704663C2777673923 @default.
- W29704663 hasConceptScore W29704663C2780846639 @default.
- W29704663 hasConceptScore W29704663C502942594 @default.
- W29704663 hasConceptScore W29704663C71924100 @default.
- W29704663 hasConceptScore W29704663C81603835 @default.
- W29704663 hasConceptScore W29704663C98274493 @default.
- W29704663 hasIssue "16" @default.
- W29704663 hasLocation W297046631 @default.
- W29704663 hasOpenAccess W29704663 @default.
- W29704663 hasPrimaryLocation W297046631 @default.
- W29704663 hasRelatedWork W1433492115 @default.
- W29704663 hasRelatedWork W1687284257 @default.
- W29704663 hasRelatedWork W1978297280 @default.
- W29704663 hasRelatedWork W2071756659 @default.
- W29704663 hasRelatedWork W2095839283 @default.
- W29704663 hasRelatedWork W2116714054 @default.
- W29704663 hasRelatedWork W2490032792 @default.
- W29704663 hasRelatedWork W29704663 @default.
- W29704663 hasRelatedWork W3168221830 @default.
- W29704663 hasRelatedWork W49938345 @default.
- W29704663 hasVolume "125" @default.
- W29704663 isParatext "false" @default.
- W29704663 isRetracted "false" @default.
- W29704663 magId "29704663" @default.
- W29704663 workType "article" @default.